About Ultragenyx (RARE)
Ultragenyx Pharmaceutical Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of products for the treatment of genetic diseases. Its clinical-stage pipeline... Read more
- USD42.77
- USD43.12
- USD41.81
- USD54.98
- -9.20%
- 443M
- 661.87k
- 784.68k
- 3.6B
- 31.52
- -1.30%
Stock News
2 hours ago
AI Powers This IBD 50 Logistics Leader; Sales Look To Soar 90%
Yahoo
3 hours ago
Jim Cramer Says “Hang On To Stocks” and Recommends 10 Stocks
Yahoo
3 hours ago
Intel Claims It's On Track To Catch Up By 2026 Despite A Lackluster Outlook
Yahoo
3 hours ago
We are trimming a large position to take some profits in this overbought market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
